Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

6,425 public trials 530 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Completed

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

NCT01676116

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
View all 109 locations
View Trial Details
Completed

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

NCT01952145

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Los Alamitos, California, United States
  • Novo Nordisk Investigational Site Palm Springs, California, United States
  • Novo Nordisk Investigational Site San Diego, California, United States
View all 91 locations
View Trial Details
Completed

A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

NCT02034513

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 99 locations
View Trial Details
Completed

Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

NCT03087877

Conditions
Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
Locations
  • AMCR Escondido, California, United States
  • William Sansum Diabetes Center Santa Barbara, California, United States
  • Diablo Clinical Research Walnut Creek, California, United States
  • Rainier Clinical Research Center Inc Renton, Washington, United States
View Trial Details
Completed

Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

NCT02229396

Conditions
Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • Research Site Tuscumbia, Alabama, United States
  • Research Site Glendale, Arizona, United States
View all 133 locations
View Trial Details
Completed

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

NCT02040441

Conditions
Cardiovascular Diseases, Chronic Disease, Diabetes Complications, +23 more
Locations
  • Universitair Ziekenhuis Ghent, Belgium
  • Institut Klinické a Experimentální Mediciny Prague, Czechia
  • Universita Karlova v Praze Prague, Czechia
  • Steno Diabets Center Copenhagen Gentofte Municipality, Denmark
View all 15 locations
View Trial Details
Completed

A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01059812

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong
  • Novo Nordisk Investigational Site Chūōku, Japan
  • Novo Nordisk Investigational Site Imizu-shi, Japan
  • Novo Nordisk Investigational Site Kamakura-shi, Japan
View all 46 locations
View Trial Details

Related conditions